BRAIN Biotech AG (LON:0RFI)
London · Delayed Price · Currency is GBP · Price in EUR 2.290
+0.020 (0.88%)
At close: Feb 9, 2026
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of 42.48 million as of February 9, 2026. Its market cap has decreased by -27.32% in one year.
Market Cap
42.48M
Enterprise Value
55.00M
Revenue
43.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.29
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 116.58M to 42.48M, a decrease of -63.56%. That is a compound annual growth rate of -9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 42.48M | -11.63% |
| Dec 30, 2025 | 48.07M | -25.25% |
| Dec 30, 2024 | 64.31M | -7.32% |
| Dec 29, 2023 | 69.39M | -38.69% |
| Dec 30, 2022 | 113.17M | -33.61% |
| Dec 30, 2021 | 170.45M | 5.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LendInvest | 48.88M |
| Upland Resources | 48.81M |
| Time Finance | 48.59M |
| RM Infrastructure Income | 47.98M |
| Octopus Future Generations VCT | 47.49M |
| Alkemy Capital Investments | 42.77M |
| Palace Capital | 42.67M |
| Cobra Resources | 42.11M |